Loading…
Carrier-mediated transport of clonidine in human keratinocytes
The alpha-2 agonist clonidine is frequently used in transdermal therapeutic systems for antihypertensive therapy. This study was performed to characterize transport of clonidine into human keratinocytes. The uptake of [3H]clonidine was measured into monolayers of the human cell line HaCaT and normal...
Saved in:
Published in: | European journal of pharmaceutical sciences 2004-02, Vol.21 (2-3), p.309-312 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c448t-d7b064420eba7414648e2608cd2c3b1f6206d85cd96b009a9b194a7f50cf46b73 |
---|---|
cites | cdi_FETCH-LOGICAL-c448t-d7b064420eba7414648e2608cd2c3b1f6206d85cd96b009a9b194a7f50cf46b73 |
container_end_page | 312 |
container_issue | 2-3 |
container_start_page | 309 |
container_title | European journal of pharmaceutical sciences |
container_volume | 21 |
creator | Grafe, Franziska Wohlrab, Wolfgang Neubert, Reinhard Brandsch, Matthias |
description | The alpha-2 agonist clonidine is frequently used in transdermal therapeutic systems for antihypertensive therapy. This study was performed to characterize transport of clonidine into human keratinocytes. The uptake of [3H]clonidine was measured into monolayers of the human cell line HaCaT and normal human epidermal keratinocytes in primary culture. The uptake of clonidine was linear for up to 1min, independent of Na+, but pH-dependent. Uptake was carrier-mediated with an affinity constant (Kt) of 0.30mM and a maximal velocity (Vmax) of 15.7nmol/min per mg of protein. Diphenhydramine, guanabenz, procainamide, tryptamine, quinine, and quinidine, but not choline markedly inhibited clonidine uptake. We conclude that clonidine is transported into keratinocytes in a pH-dependent manner by a saturable uptake system different from the keratinocyte choline transporter. The substrate specificity of the system corresponds to that of the recently characterized system for tertiary amines. After diffusion of the drugs through the stratum corneum, this transport system might contribute to the passage of clonidine and diphenhydramine across the living epidermis after dermal administration. |
doi_str_mv | 10.1016/j.ejps.2003.10.023 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_80129066</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0928098703002987</els_id><sourcerecordid>80129066</sourcerecordid><originalsourceid>FETCH-LOGICAL-c448t-d7b064420eba7414648e2608cd2c3b1f6206d85cd96b009a9b194a7f50cf46b73</originalsourceid><addsrcrecordid>eNp90M9LwzAUwPEgis7pP-BBetFb50uaJimIIMNfMPCi55Cmr5jatTPphP33pqywm6dA-L6X8CHkisKCAhV3zQKbTVgwgCxeLIBlR2RGlSxSkAyOyQwKplIolDwj5yE0ACCUhFNyRrnMZQ7ZjDwsjfcOfbrGypkBq2Twpgub3g9JXye27TtXuQ4T1yVf27Xpkm_0ZnBdb3cDhgtyUps24OV0zsnn89PH8jVdvb-8LR9XqeVcDWklSxCcM8DSSE654AqZAGUrZrOS1oKBqFRuq0KUAIUpSlpwI-scbM1FKbM5ud3v3fj-Z4th0GsXLLat6bDfBq2AsgKEiCHbh9b3IXis9ca7tfE7TUGParrRo5oe1ca7qBaHrqft2zI6HEYmphjcTIEJ1rR1JLIuHLqcKwVsfP1-32G0-I2sOliHnY22Hu2gq979948_8cqKcg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>80129066</pqid></control><display><type>article</type><title>Carrier-mediated transport of clonidine in human keratinocytes</title><source>ScienceDirect Freedom Collection</source><creator>Grafe, Franziska ; Wohlrab, Wolfgang ; Neubert, Reinhard ; Brandsch, Matthias</creator><creatorcontrib>Grafe, Franziska ; Wohlrab, Wolfgang ; Neubert, Reinhard ; Brandsch, Matthias</creatorcontrib><description>The alpha-2 agonist clonidine is frequently used in transdermal therapeutic systems for antihypertensive therapy. This study was performed to characterize transport of clonidine into human keratinocytes. The uptake of [3H]clonidine was measured into monolayers of the human cell line HaCaT and normal human epidermal keratinocytes in primary culture. The uptake of clonidine was linear for up to 1min, independent of Na+, but pH-dependent. Uptake was carrier-mediated with an affinity constant (Kt) of 0.30mM and a maximal velocity (Vmax) of 15.7nmol/min per mg of protein. Diphenhydramine, guanabenz, procainamide, tryptamine, quinine, and quinidine, but not choline markedly inhibited clonidine uptake. We conclude that clonidine is transported into keratinocytes in a pH-dependent manner by a saturable uptake system different from the keratinocyte choline transporter. The substrate specificity of the system corresponds to that of the recently characterized system for tertiary amines. After diffusion of the drugs through the stratum corneum, this transport system might contribute to the passage of clonidine and diphenhydramine across the living epidermis after dermal administration.</description><identifier>ISSN: 0928-0987</identifier><identifier>EISSN: 1879-0720</identifier><identifier>DOI: 10.1016/j.ejps.2003.10.023</identifier><identifier>PMID: 14757503</identifier><language>eng</language><publisher>Shannon: Elsevier B.V</publisher><subject>Administration, Cutaneous ; Adrenergic alpha-Agonists - administration & dosage ; Adrenergic alpha-Agonists - pharmacokinetics ; Biological and medical sciences ; Biological Transport - drug effects ; Cells, Cultured ; Clonidine - administration & dosage ; Clonidine - pharmacokinetics ; Clonidine transport ; Depression, Chemical ; Drug Carriers ; Drug delivery ; Epidermis - cytology ; Epidermis - metabolism ; General pharmacology ; HaCaT cells ; Humans ; Hydrogen-Ion Concentration ; Infant, Newborn ; Keratinocytes ; Keratinocytes - metabolism ; Medical sciences ; Pharmaceutical technology. Pharmaceutical industry ; Pharmacology. Drug treatments ; Time Factors</subject><ispartof>European journal of pharmaceutical sciences, 2004-02, Vol.21 (2-3), p.309-312</ispartof><rights>2003 Elsevier B.V.</rights><rights>2004 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c448t-d7b064420eba7414648e2608cd2c3b1f6206d85cd96b009a9b194a7f50cf46b73</citedby><cites>FETCH-LOGICAL-c448t-d7b064420eba7414648e2608cd2c3b1f6206d85cd96b009a9b194a7f50cf46b73</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=15488026$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/14757503$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Grafe, Franziska</creatorcontrib><creatorcontrib>Wohlrab, Wolfgang</creatorcontrib><creatorcontrib>Neubert, Reinhard</creatorcontrib><creatorcontrib>Brandsch, Matthias</creatorcontrib><title>Carrier-mediated transport of clonidine in human keratinocytes</title><title>European journal of pharmaceutical sciences</title><addtitle>Eur J Pharm Sci</addtitle><description>The alpha-2 agonist clonidine is frequently used in transdermal therapeutic systems for antihypertensive therapy. This study was performed to characterize transport of clonidine into human keratinocytes. The uptake of [3H]clonidine was measured into monolayers of the human cell line HaCaT and normal human epidermal keratinocytes in primary culture. The uptake of clonidine was linear for up to 1min, independent of Na+, but pH-dependent. Uptake was carrier-mediated with an affinity constant (Kt) of 0.30mM and a maximal velocity (Vmax) of 15.7nmol/min per mg of protein. Diphenhydramine, guanabenz, procainamide, tryptamine, quinine, and quinidine, but not choline markedly inhibited clonidine uptake. We conclude that clonidine is transported into keratinocytes in a pH-dependent manner by a saturable uptake system different from the keratinocyte choline transporter. The substrate specificity of the system corresponds to that of the recently characterized system for tertiary amines. After diffusion of the drugs through the stratum corneum, this transport system might contribute to the passage of clonidine and diphenhydramine across the living epidermis after dermal administration.</description><subject>Administration, Cutaneous</subject><subject>Adrenergic alpha-Agonists - administration & dosage</subject><subject>Adrenergic alpha-Agonists - pharmacokinetics</subject><subject>Biological and medical sciences</subject><subject>Biological Transport - drug effects</subject><subject>Cells, Cultured</subject><subject>Clonidine - administration & dosage</subject><subject>Clonidine - pharmacokinetics</subject><subject>Clonidine transport</subject><subject>Depression, Chemical</subject><subject>Drug Carriers</subject><subject>Drug delivery</subject><subject>Epidermis - cytology</subject><subject>Epidermis - metabolism</subject><subject>General pharmacology</subject><subject>HaCaT cells</subject><subject>Humans</subject><subject>Hydrogen-Ion Concentration</subject><subject>Infant, Newborn</subject><subject>Keratinocytes</subject><subject>Keratinocytes - metabolism</subject><subject>Medical sciences</subject><subject>Pharmaceutical technology. Pharmaceutical industry</subject><subject>Pharmacology. Drug treatments</subject><subject>Time Factors</subject><issn>0928-0987</issn><issn>1879-0720</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><recordid>eNp90M9LwzAUwPEgis7pP-BBetFb50uaJimIIMNfMPCi55Cmr5jatTPphP33pqywm6dA-L6X8CHkisKCAhV3zQKbTVgwgCxeLIBlR2RGlSxSkAyOyQwKplIolDwj5yE0ACCUhFNyRrnMZQ7ZjDwsjfcOfbrGypkBq2Twpgub3g9JXye27TtXuQ4T1yVf27Xpkm_0ZnBdb3cDhgtyUps24OV0zsnn89PH8jVdvb-8LR9XqeVcDWklSxCcM8DSSE654AqZAGUrZrOS1oKBqFRuq0KUAIUpSlpwI-scbM1FKbM5ud3v3fj-Z4th0GsXLLat6bDfBq2AsgKEiCHbh9b3IXis9ca7tfE7TUGParrRo5oe1ca7qBaHrqft2zI6HEYmphjcTIEJ1rR1JLIuHLqcKwVsfP1-32G0-I2sOliHnY22Hu2gq979948_8cqKcg</recordid><startdate>20040201</startdate><enddate>20040201</enddate><creator>Grafe, Franziska</creator><creator>Wohlrab, Wolfgang</creator><creator>Neubert, Reinhard</creator><creator>Brandsch, Matthias</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20040201</creationdate><title>Carrier-mediated transport of clonidine in human keratinocytes</title><author>Grafe, Franziska ; Wohlrab, Wolfgang ; Neubert, Reinhard ; Brandsch, Matthias</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c448t-d7b064420eba7414648e2608cd2c3b1f6206d85cd96b009a9b194a7f50cf46b73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Administration, Cutaneous</topic><topic>Adrenergic alpha-Agonists - administration & dosage</topic><topic>Adrenergic alpha-Agonists - pharmacokinetics</topic><topic>Biological and medical sciences</topic><topic>Biological Transport - drug effects</topic><topic>Cells, Cultured</topic><topic>Clonidine - administration & dosage</topic><topic>Clonidine - pharmacokinetics</topic><topic>Clonidine transport</topic><topic>Depression, Chemical</topic><topic>Drug Carriers</topic><topic>Drug delivery</topic><topic>Epidermis - cytology</topic><topic>Epidermis - metabolism</topic><topic>General pharmacology</topic><topic>HaCaT cells</topic><topic>Humans</topic><topic>Hydrogen-Ion Concentration</topic><topic>Infant, Newborn</topic><topic>Keratinocytes</topic><topic>Keratinocytes - metabolism</topic><topic>Medical sciences</topic><topic>Pharmaceutical technology. Pharmaceutical industry</topic><topic>Pharmacology. Drug treatments</topic><topic>Time Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Grafe, Franziska</creatorcontrib><creatorcontrib>Wohlrab, Wolfgang</creatorcontrib><creatorcontrib>Neubert, Reinhard</creatorcontrib><creatorcontrib>Brandsch, Matthias</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of pharmaceutical sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Grafe, Franziska</au><au>Wohlrab, Wolfgang</au><au>Neubert, Reinhard</au><au>Brandsch, Matthias</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Carrier-mediated transport of clonidine in human keratinocytes</atitle><jtitle>European journal of pharmaceutical sciences</jtitle><addtitle>Eur J Pharm Sci</addtitle><date>2004-02-01</date><risdate>2004</risdate><volume>21</volume><issue>2-3</issue><spage>309</spage><epage>312</epage><pages>309-312</pages><issn>0928-0987</issn><eissn>1879-0720</eissn><abstract>The alpha-2 agonist clonidine is frequently used in transdermal therapeutic systems for antihypertensive therapy. This study was performed to characterize transport of clonidine into human keratinocytes. The uptake of [3H]clonidine was measured into monolayers of the human cell line HaCaT and normal human epidermal keratinocytes in primary culture. The uptake of clonidine was linear for up to 1min, independent of Na+, but pH-dependent. Uptake was carrier-mediated with an affinity constant (Kt) of 0.30mM and a maximal velocity (Vmax) of 15.7nmol/min per mg of protein. Diphenhydramine, guanabenz, procainamide, tryptamine, quinine, and quinidine, but not choline markedly inhibited clonidine uptake. We conclude that clonidine is transported into keratinocytes in a pH-dependent manner by a saturable uptake system different from the keratinocyte choline transporter. The substrate specificity of the system corresponds to that of the recently characterized system for tertiary amines. After diffusion of the drugs through the stratum corneum, this transport system might contribute to the passage of clonidine and diphenhydramine across the living epidermis after dermal administration.</abstract><cop>Shannon</cop><pub>Elsevier B.V</pub><pmid>14757503</pmid><doi>10.1016/j.ejps.2003.10.023</doi><tpages>4</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0928-0987 |
ispartof | European journal of pharmaceutical sciences, 2004-02, Vol.21 (2-3), p.309-312 |
issn | 0928-0987 1879-0720 |
language | eng |
recordid | cdi_proquest_miscellaneous_80129066 |
source | ScienceDirect Freedom Collection |
subjects | Administration, Cutaneous Adrenergic alpha-Agonists - administration & dosage Adrenergic alpha-Agonists - pharmacokinetics Biological and medical sciences Biological Transport - drug effects Cells, Cultured Clonidine - administration & dosage Clonidine - pharmacokinetics Clonidine transport Depression, Chemical Drug Carriers Drug delivery Epidermis - cytology Epidermis - metabolism General pharmacology HaCaT cells Humans Hydrogen-Ion Concentration Infant, Newborn Keratinocytes Keratinocytes - metabolism Medical sciences Pharmaceutical technology. Pharmaceutical industry Pharmacology. Drug treatments Time Factors |
title | Carrier-mediated transport of clonidine in human keratinocytes |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T23%3A04%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Carrier-mediated%20transport%20of%20clonidine%20in%20human%20keratinocytes&rft.jtitle=European%20journal%20of%20pharmaceutical%20sciences&rft.au=Grafe,%20Franziska&rft.date=2004-02-01&rft.volume=21&rft.issue=2-3&rft.spage=309&rft.epage=312&rft.pages=309-312&rft.issn=0928-0987&rft.eissn=1879-0720&rft_id=info:doi/10.1016/j.ejps.2003.10.023&rft_dat=%3Cproquest_cross%3E80129066%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c448t-d7b064420eba7414648e2608cd2c3b1f6206d85cd96b009a9b194a7f50cf46b73%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=80129066&rft_id=info:pmid/14757503&rfr_iscdi=true |